Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

CASE REPORT
[View FULLTEXT] [Download PDF
 
Year : 2018  |  Volume : 64  |  Issue : 1  |  Page : 53-55  

Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult

MF Devine1, C Herrin1, W Warnack1, D Dubey2 
1 Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas, USA
2 Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA

Correspondence Address:
Dr. M F Devine
Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas
USA

We report a case of a 36-year-old man with a medical history of human immunodeficiency virus (HIV) infection who presented with hypomimia, hypophonia, bradykinesia, rigidity, and freezing of gait. His clinical presentation and magnetic resonance imaging were consistent with HIV encephalopathy with involvement of the bilateral basal ganglia and diffuse leukoencephalopathy. We initiated a trial of carbidopa-levodopa. The dose was escalated to 1050 mg levodopa daily. Amantadine was also started. The patient was closely monitored for behavioral, neurological, or systemic side effects. He tolerated therapy well without adverse effects. The patient's neurological status significantly improved with levodopa, including hypomimia, hypophonia, bradykinesia, and fluidity of gait. This case demonstrates that carbidopa-levodopa can be safely utilized to manage parkinsonism in an adult patient with HIV encephalopathy.


How to cite this article:
Devine M F, Herrin C, Warnack W, Dubey D. Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult.J Postgrad Med 2018;64:53-55


How to cite this URL:
Devine M F, Herrin C, Warnack W, Dubey D. Novel use of levodopa in human immunodeficiency virus encephalopathy-mediated parkinsonism in an adult. J Postgrad Med [serial online] 2018 [cited 2019 Dec 7 ];64:53-55
Available from: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2018;volume=64;issue=1;spage=53;epage=55;aulast=Devine;type=0


 
Saturday, December 7, 2019
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer